scholarly article | Q13442814 |
P2093 | author name string | Peter S Friedmann | |
Rocio T Martinez-Nunez | |||
Tilman Sanchez-Elsner | |||
Fethi Louafi | |||
P2860 | cites work | C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans | Q24537682 |
Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder | Q24649158 | ||
miRBase: tools for microRNA genomics | Q24649872 | ||
Requirement of bic/microRNA-155 for normal immune function | Q24656120 | ||
RNAhybrid: microRNA target prediction easy, fast and flexible | Q24680189 | ||
MicroRNA-155 is induced during the macrophage inflammatory response | Q24683841 | ||
DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis | Q24816920 | ||
Prediction of mammalian microRNA targets | Q27860498 | ||
Dendritic cells and the control of immunity | Q27860918 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells | Q28138968 | ||
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate | Q28298291 | ||
Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses | Q28616569 | ||
The role of site accessibility in microRNA target recognition | Q29547436 | ||
Regulation of the germinal center response by microRNA-155 | Q29547777 | ||
Small non-coding RNAs in animal development | Q29616776 | ||
microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells | Q29619307 | ||
Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock | Q29619768 | ||
DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes | Q33250086 | ||
Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN | Q33321821 | ||
MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts | Q34521975 | ||
KRAB can repress lentivirus proviral transcription independently of integration site | Q34568487 | ||
Dendritic-cell control of pathogen-driven T-cell polarization | Q35597117 | ||
Immunoregulation of dendritic cells | Q36256306 | ||
DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells | Q36399522 | ||
SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. | Q36399613 | ||
Structural requirements for multimerization of the pathogen receptor dendritic cell-specific ICAM3-grabbing non-integrin (CD209) on the cell surface. | Q38295432 | ||
CCR5-, DC-SIGN-dependent endocytosis and delayed reverse transcription after human immunodeficiency virus type 1 infection in human astrocytes. | Q38968677 | ||
Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin | Q39482203 | ||
DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. | Q40325520 | ||
Regulated expression of the pathogen receptor dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin in THP-1 human leukemic cells, monocytes, and macrophages. | Q40568912 | ||
Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. | Q40578638 | ||
Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor | Q40637210 | ||
Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
Role of PU.1 in hematopoiesis | Q41706344 | ||
Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. | Q42110792 | ||
PU.1 regulates the tissue-specific expression of dendritic cell-specific intercellular adhesion molecule (ICAM)-3-grabbing nonintegrin | Q42481874 | ||
The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells | Q44368038 | ||
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. | Q47597394 | ||
DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. | Q50335867 | ||
Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors. | Q52002605 | ||
Myeloid development is selectively disrupted in PU.1 null mice. | Q52530558 | ||
An efficient and economic enhancer mix for PCR | Q57015951 | ||
Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis | Q79561745 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell biology | Q7141 |
microRNA | Q310899 | ||
dendritic cell | Q506253 | ||
P304 | page(s) | 16334-42 | |
P577 | publication date | 2009-06-12 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN) | |
P478 | volume | 284 |
Q37843041 | A mini-review: microRNA in arthritis |
Q34426498 | A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages |
Q53349312 | Age-associated changes in microRNA expression in bone marrow derived dendritic cells. |
Q36137094 | Airway Secretory microRNAome Changes during Rhinovirus Infection in Early Childhood |
Q50600015 | Alcohol-induced miR-155 and HDAC11 inhibit negative regulators of the TLR4 pathway and lead to increased LPS responsiveness of Kupffer cells in alcoholic liver disease. |
Q38814139 | Anti-Inflammatory Activity of Tanshinone IIA in LPS-Stimulated RAW264.7 Macrophages via miRNAs and TLR4-NF-κB Pathway |
Q37461841 | BRCA1 and microRNAs: emerging networks and potential therapeutic targets |
Q39274912 | Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer. |
Q90131561 | Biomarkers for Detecting Resilience against Mycobacterial Disease in Animals |
Q36925894 | Chemical transfection of dye-conjugated microRNA precursors for microRNA functional analysis of M2 macrophages. |
Q35082573 | Cocaine enhances HIV-1 infectivity in monocyte derived dendritic cells by suppressing microRNA-155. |
Q33560349 | DC - SIGNR by influencing the lncRNA HNRNPKP2 upregulates the expression of CXCR4 in gastric cancer liver metastasis |
Q50003897 | Delivery of an miR155 inhibitor by anti-CD20 single-chain antibody into B cells reduces the acetylcholine receptor-specific autoantibodies and ameliorates experimental autoimmune myasthenia gravis |
Q41837797 | Differential expression of circulating microRNAs in blood and haematoma samples from patients with intracerebral haemorrhage |
Q58769098 | Differentially Tolerized Mouse Antigen Presenting Cells Share a Common miRNA Signature Including Enhanced mmu-miR-223-3p Expression Which Is Sufficient to Imprint a Protolerogenic State |
Q39658646 | Differentially expressed microRNAs regulate plasmacytoid vs. conventional dendritic cell development |
Q27311264 | Distinct peripheral blood RNA responses to Salmonella in pigs differing in Salmonella shedding levels: intersection of IFNG, TLR and miRNA pathways |
Q33992250 | Effect of aging on microRNAs and regulation of pathogen recognition receptors |
Q57476770 | Effects of Lactobacillus acidophilus and Bifidobacterium bifidum Probiotics on the Expression of MicroRNAs 135b, 26b, 18a and 155, and Their Involving Genes in Mice Colon Cancer |
Q90312408 | Epigenetic Regulation of Innate Immunity by microRNAs |
Q26853486 | Epigenetics and childhood asthma: current evidence and future research directions |
Q58998648 | Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice |
Q38905804 | Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-β in hepatocytes |
Q36401939 | Expression, circulation, and excretion profile of microRNA-21, -155, and -18a following acute kidney injury |
Q26851267 | Functional regulation of monocyte-derived dendritic cells by microRNAs |
Q35905677 | Genome-wide whole blood microRNAome and transcriptome analyses reveal miRNA-mRNA regulated host response to foodborne pathogen Salmonella infection in swine. |
Q37287774 | HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells |
Q35676143 | HIV-1 gp120 influences the expression of microRNAs in human monocyte-derived dendritic cells via STAT3 activation |
Q21562669 | Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner |
Q57927122 | Human FungalFungal Infections: Emerging Role of Small Non-coding RNAs as Modulators of Host-pathogen Interactions |
Q34567949 | Identification of host miRNAs that may limit human rhinovirus replication. |
Q34142942 | Inducible microRNA-155 Feedback Promotes Type I IFN Signaling in Antiviral Innate Immunity by Targeting Suppressor of Cytokine Signaling 1 |
Q37104892 | Inflammatory cytokine and microRNA responses of primary human dendritic cells cultured with Helicobacter pylori strains |
Q50863610 | Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response. |
Q26781552 | Interaction of drugs of abuse and microRNA with HIV: a brief review |
Q42818273 | Knockdown of PU.1 AS lncRNA inhibits adipogenesis through enhancing PU.1 mRNA translation |
Q98735449 | Macrophage Polarization in Leprosy-HIV Co-infected Patients |
Q35033664 | MiRNA in innate immune responses: novel players in wound inflammation |
Q27027300 | Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease |
Q39111001 | MicroRNA 155 and viral-induced neuroinflammation. |
Q35757383 | MicroRNA Expression Profiling of Human Respiratory Epithelium Affected by Invasive Candida Infection |
Q26798503 | MicroRNA as Type I Interferon-Regulated Transcripts and Modulators of the Innate Immune Response |
Q41908332 | MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of Toll-like receptor 4. |
Q39010112 | MicroRNA expressions associated with eosinophilic meningitis caused by Angiostrongylus cantonensis infection in a mouse model |
Q35220370 | MicroRNA function in myeloid biology |
Q45326096 | MicroRNA gga-miR-130b Suppresses Infectious Bursal Disease Virus Replication via Targeting of the Viral Genome and Cellular Suppressors of Cytokine Signaling 5. |
Q38103446 | MicroRNA in immunity and autoimmunity |
Q38994235 | MicroRNA in innate immunity and autophagy during mycobacterial infection |
Q37700271 | MicroRNA in the adaptive immune system, in sickness and in health. |
Q40312229 | MicroRNA miR-126-5p Enhances the Inflammatory Responses of Monocytes to Lipopolysaccharide Stimulation by Suppressing Cylindromatosis in Chronic HIV-1 Infection |
Q34282874 | MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis |
Q34648024 | MicroRNA profiling in human neutrophils during bone marrow granulopoiesis and in vivo exudation. |
Q38563711 | MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV. |
Q33692506 | MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients |
Q91638968 | MicroRNA-155 Controls T Helper Cell Activation During Viral Infection |
Q40407547 | MicroRNA-155 is a biomarker of T-cell activation and immune dysfunction in HIV-1-infected patients |
Q53518395 | MicroRNA-155 modulates P2R signaling and Th2 priming of dendritic cells during allergic airway inflammation in mice. |
Q39637718 | MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. |
Q49893204 | MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis |
Q35764627 | MicroRNA: implications in HIV, a brief overview |
Q38253108 | MicroRNAs affect dendritic cell function and phenotype |
Q37824264 | MicroRNAs and Multiple Sclerosis |
Q57170593 | MicroRNAs and immunity in periodontal health and disease |
Q35786288 | MicroRNAs and other mechanisms regulate interleukin-17 cytokines and receptors |
Q39268245 | MicroRNAs as regulators of drug abuse and immunity |
Q24631617 | MicroRNAs in immune regulation--opportunities for cancer immunotherapy |
Q97589581 | MicroRNAs in solid organ and vascularized composite allotransplantation: Potential biomarkers for diagnosis and therapeutic use |
Q26851141 | MicroRNAs regulate dendritic cell differentiation and function |
Q37844405 | MicroRNAs: the fine-tuners of Toll-like receptor signalling |
Q38049411 | Modulation of immune responses following solid organ transplantation by microRNA. |
Q33738902 | Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies |
Q30402626 | Mycobacterium tuberculosis subverts negative regulatory pathways in human macrophages to drive immunopathology. |
Q34143653 | NF-κB Down-regulates Expression of the B-lymphoma Marker CD10 through a miR-155/PU.1 Pathway |
Q35814995 | NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia. |
Q35293673 | Nasal mucosal microRNA expression in children with respiratory syncytial virus infection |
Q104748205 | Noninvasive biomarkers for prediction and diagnosis of heart transplantation rejection |
Q36053365 | PU.1 is involved in the immune response to Aspergillus fumigatus through upregulating Dectin-1 expression |
Q37680666 | Physiological and pathological roles for microRNAs in the immune system |
Q36228603 | Prioritizing cancer-related key miRNA-target interactions by integrative genomics |
Q40036192 | RNA Profiling in Human and Murine Transplanted Hearts: Identification and Validation of Therapeutic Targets for Acute Cardiac and Renal Allograft Rejection |
Q35850029 | Regulation of miR-24, miR-30b, and miR-142-3p during macrophage and dendritic cell differentiation potentiates innate immunity |
Q21136075 | Regulation of miRNA transcription in macrophages in response to Candida albicans |
Q35871752 | Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer |
Q51020915 | Role of MicroRNAs in the development and function of innate immune cells. |
Q85933520 | Role of growth hormone in maturation and activation of dendritic cells via miR-200a and the Keap1/Nrf2 pathway |
Q60934599 | Role of miR-155 in immune regulation and its relevance in oral lichen planus |
Q89783319 | Role of microRNAs in the Regulation of Dendritic Cell Generation and Function |
Q35196679 | Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis |
Q44322140 | Silencing of miR155 promotes the production of inflammatory mediators in Guillain-Barré syndrome in vitro |
Q34923649 | Single-cell phospho-specific flow cytometric analysis demonstrates biochemical and functional heterogeneity in human hematopoietic stem and progenitor compartments. |
Q58785770 | The Long Noncoding RNA MALAT1 Induces Tolerogenic Dendritic Cells and Regulatory T Cells miR155/Dendritic Cell-Specific Intercellular Adhesion Molecule-3 Grabbing Nonintegrin/IL10 Axis |
Q38721185 | The Role of M2000 as an Anti-inflammatory Agent in Toll-Like Receptor 2/microRNA-155 Pathway |
Q45355071 | The effect of human immunodeficiency virus-1 on monocyte-derived dendritic cell maturation and function. |
Q39628899 | The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). |
Q52890778 | The screening of a microRNA expression during development of human macrophages and mouse dendritic cells. |
Q36825857 | The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-α receptor |
Q40948508 | Toll-like Receptor 7 Is Reduced in Severe Asthma and Linked to an Altered MicroRNA Profile. |
Q47706882 | Transcriptomic Crosstalk between Fungal Invasive Pathogens and Their Host Cells: Opportunities and Challenges for Next-Generation Sequencing Methods. |
Q55057344 | gga-miR-155 Enhances Type I Interferon Expression and Suppresses Infectious Burse Disease Virus Replication via Targeting SOCS1 and TANK. |
Q52587340 | miR-146 and miR-155: Two Key Modulators of Immune Response and Tumor Development. |
Q48122649 | miR-155 Upregulation in Dendritic Cells Is Sufficient To Break Tolerance In Vivo by Negatively Regulating SHIP1. |
Q34923751 | miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. |
Q39241429 | miR-451 regulates dendritic cell cytokine responses to influenza infection. |
Q30496532 | miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate |
Q41676741 | microRNA and Wound Healing |
Q64065244 | microRNA-155 inhibition restores Fibroblast Growth Factor 7 expression in diabetic skin and decreases wound inflammation |
Q36903302 | microRNA-mediated regulation of innate immune response in rheumatic diseases |
Q37642868 | microRNAs in inflammation |
Q37981604 | microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis |
Search more.